Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenfluramine in Infants With Dravet Syndrome
NCT06118255Phase 3Completed
- Sponsor
- UCB
- Start
- May 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of fenfluramine in Dravet syndrome, sponsored by UCB. Started May 2024; status: completed.
02
Drugs
fenfluramine
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT06118255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118255.